BidaskClub upgraded shares of Atrion (NASDAQ:ATRI) from a hold rating to a buy rating in a research report report published on Thursday.
ATRI stock traded up $3.00 on Thursday, reaching $713.00. The company’s stock had a trading volume of 6,000 shares, compared to its average volume of 7,907. Atrion has a 52 week low of $516.85 and a 52 week high of $718.11. The firm has a market capitalization of $1.29 billion, a price-to-earnings ratio of 38.16 and a beta of 0.56.
Atrion (NASDAQ:ATRI) last issued its quarterly earnings data on Tuesday, August 7th. The medical instruments supplier reported $4.70 earnings per share (EPS) for the quarter. Atrion had a return on equity of 17.99% and a net margin of 22.57%. The business had revenue of $38.85 million during the quarter.
Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.
Read More: Momentum Indicator: Relative Strength Index
Receive News & Ratings for Atrion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion and related companies with MarketBeat.com's FREE daily email newsletter.